首页> 外国专利> COMPOSITION FOR TREATING ARTERIAL HYPERTENSION AND CARDIOVASCULAR PATHOLOGIES ASSOCIATED THEREWITH

COMPOSITION FOR TREATING ARTERIAL HYPERTENSION AND CARDIOVASCULAR PATHOLOGIES ASSOCIATED THEREWITH

机译:治疗动脉高血压和心血管病的组合物

摘要

FIELD: medicine.;SUBSTANCE: present invention refers to medicine, namely to a composition for treating arterial hypertension and cardiovascular pathologies associated with it, consisting of taken in therapeutically effective amounts β-adrenoreceptor agonist, I1-imidazoline receptor agonist, nitrogen oxide donor, where β adrenal blocker is selected from bisoprolol, carvedilol, pindolol, atenolol, wherein the I1-imidazoline receptor agonist is selected from moxonidine and rilmenidine, wherein the nitrogen oxide donor is selected from S-nitroso-N-acetylpenicillamine and sodium nitroprusside.;EFFECT: present invention provides synergy of combined action β-adrenoreceptor blocking agents and imidazoline agonists, which enables reducing effective therapeutic doses of each of the compounds, which inevitably leads to minimization of possible side effects associated with the administration of said compounds, and the third component in the form of an NO donor minimizes the negative action of imidazoline agonists on the intracellular calcium level, which leads to more effective control of myocardial contractility and reduces the risk of calcium overload of working cardiomyocytes, preventing the development of pathophysiological events in the heart.;1 cl, 7 dwg
机译:技术领域本发明涉及药物,即用于治疗动脉高血压和与其相关的心血管疾病的组合物,其由治疗有效量的β-肾上腺素受体激动剂,I1-咪唑啉受体激动剂,氮氧化物供体,其中β肾上腺阻滞剂选自比索洛尔,卡维地洛,品多洛尔,阿替洛尔,其中I1-咪唑啉受体激动剂选自莫索尼定和利美替尼,其中氮氧化物供体选自S-亚硝基-N-乙酰青霉胺和硝普钠。 :本发明提供了联合作用的β-肾上腺素受体阻断剂和咪唑啉激动剂的协同作用,其能够降低每种化合物的有效治疗剂量,这不可避免地使与所述化合物和第三组分的给药有关的可能的副作用最小化NO供体的形式使亚胺的负面作用最小化偶氮碱激动剂在细胞内钙水平上的作用,可导致更有效地控制心肌收缩力,并降低正常心肌细胞钙超载的风险,从而防止心脏发生病理生理事件。1cl,7 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号